October 07, 2024
Press releases
Latest news
October 03, 2024
Ultragenyx Provides Update on Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease
Read more
September 26, 2024
Ultragenyx Announces Upcoming Setrusumab (UX143) Presentations at the ASBMR 2024 Annual Meeting
Read more
September 18, 2024
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Read more
August 01, 2024
Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update
Read more
July 25, 2024
Ultragenyx to Host Conference Call for Second Quarter 2024 Financial Results and Corporate Update
Read more
July 24, 2024
Ultragenyx to Present GTX-102 Angelman Syndrome Program Update at the ASF Family Conference and Research Symposium
Read more
Displaying 1 - 10 of 10